Putin seizes control of pharmaceutical giant with German roots
www.pravda.com.ua
Fri, 04 Apr 2025 19:03:24 +0300
Russian ruler Vladimir Putin has placed Nizhpharm, one of Russias largest pharmaceutical manufacturers, under temporary control.
Source Russian Telegram channel The Bell Details The relevant decree applies to 100 of the shares held by the Luxembourgbased company Nidda Lynx S.A.R.L., part of the German group Stada.
The new temporary administrator of the assets is the Russian company Pharmirus.
Founded in 2020, Pharmirus specialises in the supply of medicines.
In 2022, the company reported losses, with revenue of around RUB 92 million US1million.
Nizhpharm is one of Russias oldest drug manufacturers, established in 1919.
Stada acquired a controlling stake in the company in 2004.
Following the beginning of the fullscale war, the ownership structure changed, and control passed to Stadas Luxembourg subsidiary.
DSM Groups data indicates that in 2024 Nizhpharm ranked second in Russia for pharmacy sales in roubles 3.7 of the market and third in terms of packaging volume 3.8.
The companys annual revenue grew by 11.2 to reach RUB 59.8 billion US650 million.
Its portfolio includes more than 100 brands, such as Edarbi, Ermital, Artra, Ibuprofen, Diclofenac and Vitrum vitamins.
Background Despite official statements claiming a high number of companies from unfriendly countries want to return to Russia, not a single one has applied to resume operations on the Russian market.
Support Ukrainska Pravda on Patreon
Latest news
more news